BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:A Phenotypic Screening Technology Aimed at Drugging Undruggable Targets
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_649206_0
SUMMARY:A Phenotypic Screening Technology Aimed at Drugging Undruggable Targets
DESCRIPTION:<p><strong>Guest speaker:</strong><br><em><strong>Chris Torrance, PhD</strong></em><br>CEO and Co-founder<br>PhoreMost, Ltd.<br>Cambridge, UK</p>
LOCATION:Dana-Farber Cancer Institute, Yawkey 308, 450 Brookline Avenue, Boston, MA
STATUS:CONFIRMED
DTSTART:20160223T190000Z
DTEND:20160223T200000Z
END:VEVENT
END:VCALENDAR